Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Hepatocellular 4Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1NSCLC 1Locally Advanced Gastric Cancer 1Liver Neoplasms 1Liver Diseases 1Esophageal Neoplasms 1Cervical Cancer Metastatic 1Advanced Gastric Cancer 1Advanced Colorectal Carcinoma 1

Interventions

famitinib 1camrelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cervical Cancer Metastatic × camrelizumab × Clear all
NCT07266350 2025-12-05

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

Chongqing University Cancer Hospital

Not yet recruiting
1,300 enrolled
Gynecologic

Cervical Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡